|
|
4D IMRT: Stereotactic body radiotherapy for lung cancer
|
7R01CA093626-08
|
$260,491
|
$26,049
|
KEALL, PAUL
|
UNIVERSITY OF SYDNEY
|
|
|
A Genetic Screen for HCC Genes
|
5R01CA132962-02
|
$302,919
|
$302,919
|
LARGAESPADA, DAVID
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
|
A Multidisciplinary and Translational Approach to Hepatobiliary Malignancy
|
5K24CA139570-02
|
$186,940
|
$186,940
|
Nelson, David
|
UNIVERSITY OF FLORIDA
|
|
|
A New Method for Improved Targeting in Image-guided Abdominal Interventions
|
5R01CA138586-02
|
$358,940
|
$358,940
|
Hata, Nobuhiko
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
A Randomized Trial of Hep B Screening and Vaccination in High Risk Vietnamese
|
5R01CA129763-05
|
$1
|
$1
|
MA, GRACE
|
TEMPLE UNIVERSITY
|
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$1,178,242
|
$58,912
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
|
Aberrant DNA Methylation of MicroRNA Genes in Hepatocellular Carcinoma (HCC)
|
1R03CA156629-01A1
|
$80,000
|
$80,000
|
Shen, Jing
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Abramson Cancer Center Support Grant
|
2P30CA016520-35
|
$7,696,742
|
$76,967
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-35S1
|
$50,000
|
$500
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Academic Training in Medical Oncology
|
3T32CA009297-28S1
|
$66,919
|
$3,346
|
RIBAS, ANTONI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
Academic Training in Medical Oncology
|
5T32CA009297-28
|
$316,308
|
$15,815
|
RIBAS, ANTONI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
AIDS Malignancy Clinical Trials Consortium (AMC)
|
3U01CA121947-04S1
|
$200,000
|
$10,000
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
AIDS Malignancy Clinical Trials Consortium (AMC)
|
3U01CA121947-04S2
|
$450,000
|
$22,500
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
AIDS Malignancy Clinical Trials Consortium (AMC)
|
3U01CA121947-04S3
|
$150,000
|
$7,500
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
AIDS Malignancy Clinical Trials Consortium (AMC)
|
5U01CA121947-05
|
$5,189,968
|
$259,498
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
Alcohol and Iron Derived Oxidant Stress Impact Epigenetic Regulation
|
5R21CA133701-02
|
$149,793
|
$149,793
|
WILKINSON IV, JOHN
|
MARSHALL UNIVERSITY
|
|
|
American College of Radiology Imaging Network
|
5U01CA080098-13
|
$7,455,878
|
$1,863,970
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
An Integrated System for Image-Guided Radiofrequency Ablation of Liver Tumors
|
7R01CA124377-05
|
$343,716
|
$343,716
|
CLEARY, KEVIN
|
CHILDREN'S RESEARCH INSTITUTE
|
|
|
An integrative approach to cancer gene discovery in hepatocellular carcinoma
|
5R01CA124648-05
|
$435,619
|
$304,933
|
POWERS, SCOTT
|
COLD SPRING HARBOR LABORATORY
|
|
|
Analyses of the Molecular Functions for D-Cyclins
|
5R01CA108420-08
|
$448,113
|
$134,434
|
SICINSKI, PIOTR
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Analysis of a novel regulator of hepatocellular carcinoma
|
3R01CA138540-02S1
|
$47,686
|
$47,686
|
SARKAR, DEVANAND
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
Analysis of a novel regulator of hepatocellular carcinoma
|
5R01CA138540-02
|
$300,907
|
$300,907
|
SARKAR, DEVANAND
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
Analysis of immune suppressor mechanisms in patients with HCC
|
ZIA BC 011344
|
$248,214
|
$248,213
|
Greten, Tim
|
CCR (NCI)
|
|
|
Analysis of Imprinting Control of the Beckwith Wiedeman Domain
|
5K22CA140361-03
|
$168,380
|
$84,190
|
ENGEL, NORA
|
TEMPLE UNIVERSITY
|
|
|
Analysis of LC-MS data to identify peptide and glycan biomarkers for hepatocellul
|
5R01CA143420-02
|
$278,062
|
$278,062
|
RESSOM, HABTOM
|
GEORGETOWN UNIVERSITY
|
|
|
Androgen Receptor Roles in Liver Cancer Incidence and Progression
|
5R01CA122295-05
|
$283,822
|
$283,822
|
CHANG, CHAWNSHANG
|
UNIVERSITY OF ROCHESTER
|
|
|
Antibody Therapy of Cancer
|
ZIA BC 010891
|
$552,493
|
$220,997
|
Ho, Mitchell
|
CCR (NCI)
|
|
|
Asian American Liver Cancer Education Program in Maryland
|
3R25CA129042-04S1
|
$38,590
|
$38,590
|
JUON, HEE-SOON
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Asian American Liver Cancer Education Program in Maryland
|
5R25CA129042-04
|
$274,632
|
$274,632
|
JUON, HEE-SOON
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Asian Community Cancer Health Disparities Center (ACCHDC)
|
3U54CA153513-02S1
|
$45,000
|
$7,200
|
MA, GRACE
|
TEMPLE UNIVERSITY
|
|
|
Asian Community Cancer Health Disparities Center (ACCHDC)
|
5U54CA153513-02
|
$1,074,909
|
$171,985
|
MA, GRACE
|
TEMPLE UNIVERSITY
|
|
|
Asymmetric Division and Self Renewal of Cancer Stem Cells
|
ZIA BC 011003
|
$170,206
|
$51,061
|
Avital, Itzhak
|
CCR (NCI)
|
|
|
ATBC Study
|
ZIA CP010195-03031
|
$828,679
|
$33,147
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
|
Atlases to Report and Correlate Radiotherapy Dose Distributions with Outcomes
|
4R01CA129182-03
|
$439,902
|
$109,976
|
Jackson, Andrew
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
Automatic Three Dimensional (3D) Registration for Enhanced Cancer Management
|
5P01CA087634-08
|
$1,382,595
|
$345,649
|
Meyer, Charles
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-05S1
|
$75,000
|
$4,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-05
|
$2,934,758
|
$176,085
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
BETA-CATENIN AS A THERAPEUTIC TARGET IN HEPATOCELLULAR CANCER
|
5R01CA124414-05
|
$241,790
|
$241,790
|
MONGA, SATDARSHAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$891,092
|
$89,109
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
|
Biochemistry and Genetics of Hepatocarcinogenesis
|
3P01CA022484-29S1
|
$25,083
|
$25,083
|
BRADFIELD, CHRISTOPHER
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
Biomarker Discovery for Hepatitis C Progression using Machine Learning Techniques
|
5K25CA127524-04
|
$134,067
|
$134,067
|
Spratt, Heidi
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
|
|
Biomarker for Hepatocellular Carcinoma
|
5R01CA123544-05
|
$231,313
|
$231,313
|
Wands, Jack
|
RHODE ISLAND HOSPITAL
|
|
|
Biomarkers of Opisthorchis viverrini-induced cholangiocarcinoma
|
1R01CA155297-01
|
$571,147
|
$571,147
|
Brindley, Paul
|
GEORGE WASHINGTON UNIVERSITY
|
|
|
Biosynthesis of Selenocysteine and Its Incorporation into Protein
|
ZIA BC 010767
|
$191,044
|
$95,522
|
Hatfield, Dolph
|
CCR (NCI)
|
|
|
Bone Marrow Stem Cells Participation in Solid Organ Cancers Carcinogenesis
|
ZIA BC 011004
|
$255,308
|
$51,061
|
Avital, Itzhak
|
CCR (NCI)
|
|
|
BRIT1, A NOVEL HEPATOCELLULAR CARCINOMA TUMOR SUPPRESSOR
|
1R21CA161513-01
|
$205,277
|
$205,277
|
LI, KAIYI
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
c-Myc-regulated microRNAs in normal and pathologic cellular physiology
|
5R01CA120185-05
|
$299,893
|
$98,965
|
MENDELL, JOSHUA
|
JOHNS HOPKINS UNIVERSITY
|
|
|
CALGB Member Site: University of California - San Francisco
|
5U10CA138561-03
|
$103,395
|
$1,034
|
Ryan, Charles
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
Cancer and Leukemia Group B
|
3U10CA031946-30S1
|
$3,449,605
|
$34,496
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Cancer and Leukemia Group B
|
5U10CA031946-30
|
$10,820,362
|
$108,204
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Total relevant funding to Liver Cancer for this search: $66,161,424
|
